Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

An overview of statin-induced myopathy and perspectives for the future.

Nikolic D, Banach M, Chianetta R, Luzzu LM, Pantea Stoian A, Diaconu CC, Citarrella R, Montalto G, Rizzo M.

Expert Opin Drug Saf. 2020 Apr 1. doi: 10.1080/14740338.2020.1747431. [Epub ahead of print]

PMID:
32233708
2.

Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study.

Castellino G, Nikolic D, Magán-Fernández A, Malfa GA, Chianetta R, Patti AM, Amato A, Montalto G, Toth PP, Banach M, Cicero AFG, Rizzo M.

Nutrients. 2019 Oct 25;11(11). pii: E2580. doi: 10.3390/nu11112580.

3.

Effects of Aging and Diet on Cardioprotection and Cardiometabolic Risk Markers.

Corina A, Abrudan MB, Nikolic D, Cӑtoi AF, Chianetta R, Castellino G, Citarrella R, Stoian AP, Pérez-Martínez P, Rizzo M.

Curr Pharm Des. 2019;25(35):3704-3714. doi: 10.2174/1381612825666191105111232.

PMID:
31692432
4.

Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study.

Fadini GP, Li Volsi P, Devangelio E, Poli M, Cazzetta G, Felace G, Avogaro A; DARWIN-T2D Network.

J Endocrinol Invest. 2020 Mar;43(3):329-336. doi: 10.1007/s40618-019-01110-w. Epub 2019 Sep 12.

PMID:
31515744
5.

Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study.

Fadini GP, Sciannameo V, Franzetti I, Bottigliengo D, D'Angelo P, Vinci C, Berchialla P, Arena S, Buzzetti R, Avogaro A; DARWIN-T2D network.

Diabetes Obes Metab. 2019 Aug;21(8):1886-1894. doi: 10.1111/dom.13747. Epub 2019 May 8.

6.

Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study.

Patti AM, Nikolic D, Magan-Fernandez A, Giglio RV, Castellino G, Chianetta R, Citarrella R, Corrado E, Provenzano F, Provenzano V, Montalto G, Rizvi AA, Rizzo M.

Diabetes Res Clin Pract. 2019 Mar;149:163-169. doi: 10.1016/j.diabres.2019.02.006. Epub 2019 Feb 10.

PMID:
30759365
7.

Periodontitis and mechanisms of cardiometabolic risk: Novel insights and future perspectives.

Mesa F, Magan-Fernandez A, Castellino G, Chianetta R, Nibali L, Rizzo M.

Biochim Biophys Acta Mol Basis Dis. 2019 Feb 1;1865(2):476-484. doi: 10.1016/j.bbadis.2018.12.001. Epub 2018 Dec 5. Review.

8.

Phenotyping normal kidney function in elderly patients with type 2 diabetes: a cross-sectional multicentre study.

Fadini GP, Solini A, Manca ML, Zatti G, Karamouzis I, Di Benedetto A, Frittitta L, Avogaro A; DARWIN-T2D Network.

Acta Diabetol. 2018 Nov;55(11):1121-1129. doi: 10.1007/s00592-018-1194-z. Epub 2018 Aug 9.

PMID:
30090961
9.

Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study.

Fadini GP, Bottigliengo D, D'Angelo F, Cavalot F, Bossi AC, Zatti G, Baldi I, Avogaro A; DARWIN-T2D Network.

Diabetes Ther. 2018 Aug;9(4):1477-1490. doi: 10.1007/s13300-018-0452-y. Epub 2018 Jun 1.

10.

Natural approaches in metabolic syndrome management.

Patti AM, Al-Rasadi K, Giglio RV, Nikolic D, Mannina C, Castellino G, Chianetta R, Banach M, Cicero AFG, Lippi G, Montalto G, Rizzo M, Toth PP.

Arch Med Sci. 2018 Mar;14(2):422-441. doi: 10.5114/aoms.2017.68717. Epub 2017 Jul 19.

Supplemental Content

Loading ...
Support Center